Symbol="LIFE"
AssetType="Common Stock"
Name="aTyr Pharma Inc"
Description="aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California."
CIK="1339970"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="3545 JOHN HOPKINS COURT, STE #250, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="108041000"
EBITDA="-46582000"
PERatio="None"
PEGRatio="0"
BookValue="2.06"
DividendPerShare="0"
DividendYield="0"
EPS="-1.41"
RevenuePerShareTTM="0.325"
ProfitMargin="0"
OperatingMarginTTM="-4.507"
ReturnOnAssetsTTM="-0.242"
ReturnOnEquityTTM="-0.434"
RevenueTTM="10386000"
GrossProfitTTM="-32422000"
DilutedEPSTTM="-1.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="13.26"
AnalystTargetPrice="20.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="37.76"
PriceToBookRatio="0.831"
EVToRevenue="12.47"
EVToEBITDA="0.101"
Beta="1.25"
num_52WeekHigh="4.28"
num_52WeekLow="1.555"
num_50DayMovingAverage="2.239"
num_200DayMovingAverage="2.243"
SharesOutstanding="54292000"
DividendDate="2019-07-01"
ExDividendDate="None"
symbol="LIFE"
open="1.97"
high="2.01"
low="1.91"
price="1.93"
volume="183771.00"
latest_trading_day="2023-07-18"
previous_close="1.99"
change="-0.06"
change_percent="-3.0151%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="534191"
Change_recent_avg="-0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="494"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0111.jpeg"
image_negative_thumbnail_id_2="1139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="667"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
